These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36536744)

  • 1. Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain-Barré Syndrome in Somalia: Case series.
    Sidow NO; Hassan MS
    Ann Med Surg (Lond); 2022 Dec; 84():104816. PubMed ID: 36536744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
    Doets AY; Lingsma HF; Walgaard C; Islam B; Papri N; Davidson A; Yamagishi Y; Kusunoki S; Dimachkie MM; Waheed W; Kolb N; Islam Z; Mohammad QD; Harbo T; Sindrup SH; Chavada G; Willison HJ; Casasnovas C; Bateman K; Miller JAL; van den Berg B; Verboon C; Roodbol J; Leonhard SE; Benedetti L; Kuwabara S; Van den Bergh P; Monges S; Marfia GA; Shahrizaila N; Galassi G; Péréon Y; Bürmann J; Kuitwaard K; Kleyweg RP; Marchesoni C; Sedano Tous MJ; Querol L; Illa I; Wang Y; Nobile-Orazio E; Rinaldi S; Schenone A; Pardo J; Vermeij FH; Lehmann HC; Granit V; Cavaletti G; Gutiérrez-Gutiérrez G; Barroso FA; Visser LH; Katzberg HD; Dardiotis E; Attarian S; van der Kooi AJ; Eftimov F; Wirtz PW; Samijn JPA; Gilhuis HJ; Hadden RDM; Holt JKL; Sheikh KA; Karafiath S; Vytopil M; Antonini G; Feasby TE; Faber CG; Gijsbers CJ; Busby M; Roberts RC; Silvestri NJ; Fazio R; van Dijk GW; Garssen MPJ; Straathof CSM; Gorson KC; Jacobs BC;
    Neurology; 2022 Feb; 98(5):e518-e532. PubMed ID: 34937789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IVIG treatment and prognosis in Guillain-Barré syndrome.
    van Doorn PA; Kuitwaard K; Walgaard C; van Koningsveld R; Ruts L; Jacobs BC
    J Clin Immunol; 2010 May; 30 Suppl 1(Suppl 1):S74-8. PubMed ID: 20396937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    Eur J Neurol; 2023 Dec; 30(12):3646-3674. PubMed ID: 37814552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.
    van Doorn PA; Van den Bergh PYK; Hadden RDM; Avau B; Vankrunkelsven P; Attarian S; Blomkwist-Markens PH; Cornblath DR; Goedee HS; Harbo T; Jacobs BC; Kusunoki S; Lehmann HC; Lewis RA; Lunn MP; Nobile-Orazio E; Querol L; Rajabally YA; Umapathi T; Topaloglu HA; Willison HJ
    J Peripher Nerv Syst; 2023 Dec; 28(4):535-563. PubMed ID: 37814551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C; Jacobs BC; Lingsma HF; Steyerberg EW; Cornblath DR; van Doorn PA;
    J Peripher Nerv Syst; 2018 Dec; 23(4):210-215. PubMed ID: 30151941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, treatment and prognosis of Guillain-Barré syndrome (GBS).
    van Doorn PA
    Presse Med; 2013 Jun; 42(6 Pt 2):e193-201. PubMed ID: 23628447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of prognostic indicators for Guillain-Barré syndrome in children.
    Qinrong H; Yuxia C; Ling L; Huayu L; Lei X; Xiaoli L; Nong X
    Dev Med Child Neurol; 2023 Apr; 65(4):563-570. PubMed ID: 36175376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of Guillain-Barré syndrome prognostic models in Malaysian patients.
    Tan CY; Razali SNO; Goh KJ; Shahrizaila N
    J Peripher Nerv Syst; 2019 Jun; 24(2):168-173. PubMed ID: 31001904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome.
    van Tilburg SJ; Teunissen CE; Maas CCHM; Thomma RCM; Walgaard C; Heijst H; Huizinga R; van Doorn PA; Jacobs BC
    EBioMedicine; 2024 Apr; 102():105072. PubMed ID: 38518653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
    Yamagishi Y; Suzuki H; Sonoo M; Kuwabara S; Yokota T; Nomura K; Chiba A; Kaji R; Kanda T; Kaida K; Ikeda SI; Mutoh T; Yamasaki R; Takashima H; Matsui M; Nishiyama K; Sobue G; Kusunoki S
    J Peripher Nerv Syst; 2017 Dec; 22(4):433-439. PubMed ID: 28833828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognosis and prognostic factor of Guillain-Barré Syndrome].
    Yamagishi Y; Kusunoki S
    Rinsho Shinkeigaku; 2020 Apr; 60(4):247-252. PubMed ID: 32238748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.
    Verboon C; van den Berg B; Cornblath DR; Venema E; Gorson KC; Lunn MP; Lingsma H; Van den Bergh P; Harbo T; Bateman K; Pereon Y; Sindrup SH; Kusunoki S; Miller J; Islam Z; Hartung HP; Chavada G; Jacobs BC; Hughes RAC; van Doorn PA;
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):113-121. PubMed ID: 31586949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and evaluation of a prognostic prediction model based on the mEGOS score for patients with Guillain-Barré syndrome.
    Xue G; Zhang Y; Wang R; Yang Y; Wang H; Li J; He X; Zhang Q; Yang X
    Front Neurol; 2023; 14():1303243. PubMed ID: 38099064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Albumin Levels With Outcome in Intravenous Immunoglobulin-Treated Guillain-Barré Syndrome.
    Fokkink WR; Walgaard C; Kuitwaard K; Tio-Gillen AP; van Doorn PA; Jacobs BC
    JAMA Neurol; 2017 Feb; 74(2):189-196. PubMed ID: 28027337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh.
    Papri N; Doets AY; Mohammad QD; Endtz HP; Lingsma HF; Jacobs BC; Islam Z
    Ann Clin Transl Neurol; 2022 Aug; 9(8):1264-1275. PubMed ID: 35908170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of chief complaints to predict severity, ventilator dependence, treatment option, and short-term outcome of patients with Guillain-Barré syndrome: a retrospective study.
    Wang Y; Shang P; Xin M; Bai J; Zhou C; Zhang HL
    BMC Neurol; 2017 Nov; 17(1):200. PubMed ID: 29157205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting of Mechanical Ventilation and Outcomes by Using Models and Biomarker in Guillain-Barré Syndrome.
    Yao J; Zhou R; Liu Y; Liu Y; Cao Q; Lu Z
    Neurol Ther; 2023 Dec; 12(6):2121-2132. PubMed ID: 37792219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy for HIV-associated Guillain-Barré syndrome.
    Wang J; Zhang Y; Wang M; Ren Y; Tang M; Liu L; Zhou D
    Int Immunopharmacol; 2022 Nov; 112():109192. PubMed ID: 36155283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barré syndrome: a randomized trial.
    Korinthenberg R; Schessl J; Kirschner J; Mönting JS
    Pediatrics; 2005 Jul; 116(1):8-14. PubMed ID: 15995024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.